Press-release for stocks for adil

Prices are updated after-hours

Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
Published: 2021-02-25 (Crawled : 15:00) - globenewswire.com
ADIL | News | $1.67 -1.77% 90K

| -45.69% | O: -1.6% H: 6.82% C: -10.71%
phase 3 trial enroll

55%

45%

CSSE 4 | $0.3499 129.74% 150M

CZOO | $11.04 121.24% 9.6M

BOF | $2.05 75.21% 78M

AMST | $3.2 60.0% 63M

LICN | $0.8592 53.43% 13M

WIMI | $1.05 44.75% 13M

TROO | $1.51 38.53% 5.6M

MULN | News | $3.7 35.53% 6.4M

RILY | $27.91 28.5% 8.9M

WHLM | $6.43 26.58% 580K

Save your searches and get alerts when important news are released.